( NASDAQ-NMS:ABUS, NYSE:AXON )

News from Roivant Sciences Ltd. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Dec 15, 2016, 15:57 ET Roivant Sciences und Partnerunternehmen etablieren weltweiten Hauptsitz in der Schweiz

Roivant Sciences Ltd., ein Biopharmazie-Unternehmen mit dem Schwerpunkt der Umsetzung des vollen Wertes viel versprechender Medikamente in der...


Dec 15, 2016, 15:53 ET Roivant Sciences et ses sociétés affiliées établissent leur siège social mondial en Suisse

Roivant Sciences Ltd., une société biopharmaceutique axée sur la réalisation de la valeur totale des candidats médicaments promettant d'améliorer...


Dec 15, 2016, 08:00 ET Roivant Sciences and Affiliated Companies Establish Global Headquarters in Switzerland

Roivant Sciences Ltd., a biopharmaceutical company focused on realizing the full value of promising drug candidates to improve the lives of...


Oct 19, 2016, 16:01 ET Patrick Machado Joins Board of Directors of Roivant Sciences

Roivant Sciences Ltd., an innovative biopharmaceutical company focused on developing promising drug candidates to improve the lives of patients and...


Jul 12, 2016, 22:46 ET Roivant Sciences and Plexcera Therapeutics Announce the Formation of Enzyvant Sciences to Focus on the Treatment of Farber Disease

Roivant Sciences Ltd. and Plexcera Therapeutics LLC ("Plexcera") have announced the formation of Enzyvant Sciences Ltd. ("Enzyvant"), a new...


Jun 06, 2016, 07:00 ET Roivant Sciences and Takeda Launch Myovant Sciences to Develop Innovative Therapeutics for Women's Health and Prostate Cancer

 Takeda Pharmaceutical Company Limited (TSE: 4502) and Roivant Sciences Ltd. today announced the formation of Myovant Sciences Ltd....